Ahmud, M. W., M. Mustafa, and W. Asim. “A Rare Disease Gets a Breakthrough: Ctexli Approved for Cerebrotendinous Xanthomatosis”. International Journal of Basic & Clinical Pharmacology, vol. 14, no. 4, June 2025, pp. 649-50, doi:10.18203/2319-2003.ijbcp20251852.